TANG KEVIN sold BOLD

August 26, 2026 · Form 4 insider transaction

TANG KEVIN sold 18,300 shares of Boundless Bio, Inc. at $2.97 per share, a transaction worth $54.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
18,300
Price
$2.97
Total value
$54.4K
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 26, 2026
Filing dateAugust 28, 2026
Shares owned after2,840,635
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Reporting Persons have delivered to the Issuer the full amount of the disgorgeable profit arising the sale reported herein, in the amount of $10,046.70.; The price reported herein is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.03. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares sold at each price within the range set forth in Footnote 2.; Tang Capital Partners, LP ("TCP") beneficially owns 655,170 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 887,715 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 655,161 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 642,589 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.

View the original Form 4 on SEC EDGAR
TANG KEVIN sold BOLD: August 26, 2026 | Insider Trading Screener